Key Market Indicators
British insulin imports are projected to soar to approximately $510 million by 2028, up from nearly $487 million in 2023. This marks a steady annual growth rate of 0.6%. Over the past 25 years, the demand for insulin in the UK has increased by an average of 0.7% each year. On the export front, the UK's insulin export market is expected to reach around $84 million by 2028, rising from $74 million in 2023. This represents an annual growth rate of 1.9%. Since 1998, British insulin exports have seen a more robust average annual increase of 3.1%. In 2023, the UK ranked ninth in the global insulin export market. Belgium surpassed the UK with exports valued at $74 million. The top three positions were held by France, Italy, and China.
